iShares Nasdaq US Biotechnology varade ülevaade

£BTEK

Selle fondi eesmärk on jälgida Nasdaq Biotechnology indeksit, mis hõlmab Nasdaqil noteeritud ettevõtteid, mis tegelevad peamiselt biomeditsiiniliste teadusuuringutega, et arendada uusi ravimeetodeid ja ravimeid inimhaiguste jaoks.

ETFi osalused
Nimi	Osakaal	Turukapitalisatsioon	Hind	Muutus päeva jooksul
Amgen $AMGNTervis	8,57%			-
Vertex Pharmaceuticals $VRTXTervis	8,05%			-
Gilead Sciences $GILDTervis	7,34%			-
Regeneron $REGNTervis	5,02%			-
Revolution Medicines $RVMDTervis	2,74%			-
Alnylam Pharmaceuticals $ALNYTervis	2,7%			-
Biogen $BIIBTervis	2,13%			-
Illumina $ILMNTervis	2,05%			-
Royalty Pharma $RPRXTervis	1,86%			-
Incyte $INCYTervis	1,82%			-
Roivant Sciences $ROIVTervis	1,71%			-
argenx SE $ARGXTervis	1,69%			-
Insmed $INSMTervis	1,58%			-
United Therapeutics $UTHRTervis	1,56%			-
Moderna $MRNATervis	1,55%			-
Viatris $VTRSTervis	1,46%			-
Guardant Health $GHTervis	1,33%			-
Neurocrine $NBIXTervis	1,29%			-
BridgeBio Pharma $BBIOTervis	1,17%			-
Medpace $MEDPTervis	1,14%			-
Jazz Pharmaceuticals $JAZZTervis	1,13%			-
Ascendis Pharma $ASNDTervis	1,1%			-
Exelixis $EXELTervis	1%			-
Madrigal Pharmaceuticals $MDGLTervis	0,87%			-
Arrowhead Pharmaceuticals $ARWRTervis	0,85%			-
Axsome Therapeutics $AXSMTervis	0,85%			-
BioMarin $BMRNTervis	0,84%			-
BeOne Medicines AG $ONCTervis	0,76%			-
Cytokinetics $CYTKTervis	0,75%			-
BioNTech SE $BNTXTervis	0,75%			-
Krystal Biotech $KRYSTervis	0,75%			-
	0,74%	N/A	N/A	N/A
Halozyme Therapeutics $HALOTervis	0,69%			-
Summit Therapeutics $SMMTTervis	0,68%			-
Ionis Pharmaceuticals $IONSTervis	0,64%			-
Crinetics Pharmaceuticals $CRNXTervis	0,62%			-
Protagonist Therapeutics $PTGXTervis	0,62%			-
Kymera Therapeutic $KYMRTervis	0,61%			-
Aeglea BioTherapeutics, Inc. $SYRETervis	0,61%			-
Alkermes $ALKSTervis	0,59%			-
Apogee Therapeutics $APGETervis	0,58%			-
Praxis Precision Medicines $PRAXTervis	0,58%			-
Immunovant $IMVTTervis	0,56%			-
Vaxcyte $PCVXTervis	0,55%			-
Tempus AI $TEMTervis	0,52%			-
Rhythm Pharmaceuticals $RYTMTervis	0,52%			-
ImmunityBio $IBRXTervis	0,51%			-
ABIVAX Société Anonyme €ABVXTervis	0,5%			-
Cogent Biosciences $COGTTervis	0,49%			-
Mirum Pharmaceuticals $MIRMTervis	0,48%			-
CG Oncology $CGONTervis	0,45%			-
Xenon Pharmaceuticals $XENETervis	0,44%			-
PTC Therapeutics $PTCTTervis	0,44%			-
Amneal Pharmaceuticals $AMRXTervis	0,42%			-
Ligand Pharmaceuticals $LGNDTervis	0,42%			-
Scholar Rock $SRRKTervis	0,41%			-
Erasca $ERASTervis	0,4%			-
Twist Bioscience $TWSTTervis	0,39%			-
10x Genomics $TXGTervis	0,39%			-
Oruka Therapeutics $ORKATervis	0,38%			-
Travere Therapeutics $TVTXTervis	0,37%			-
Indivior $INDVTervis	0,35%			-
CRISPR $CRSPTervis	0,32%			-
Definium Therapeutics $DFTXTervis	0,32%			-
ACADIA Pharmaceuticals $ACADTervis	0,31%			-
Veracyte $VCYTTervis	0,31%			-
Caris Life Sciences $CAITervis	0,31%			-
Edgewise Therapeutics $EWTXTervis	0,31%			-
Dyne Therapeutics $DYNTervis	0,3%			-
Relay Therapeutics $RLAYTervis	0,28%			-
Tango Therapeutics $TNGXTervis	0,27%			-
Denali Therapeutics $DNLITervis	0,27%			-
	0,26%	N/A	N/A	N/A
Adaptive Biotechnologies $ADPTTervis	0,25%			-
Kiniksa Pharmaceuticals $KNSATervis	0,25%			-
Arcutis Biotherapeutics $ARQTTervis	0,25%			-
Enliven Therapeutics, Inc. $ELVNTervis	0,23%			-
Alumis Inc. $ALMSTervis	0,23%			-
NewAmsterdam Pharma Company N.V. $NAMSTervis	0,23%			-
IDEAYA Biosciences $IDYATervis	0,22%			-
MBX Biosciences, Inc. $MBXTervis	0,2%			-
Disc Medicine, Inc. $IRONTervis	0,2%			-
Supernus Pharmaceuticals $SUPNTervis	0,19%			-
GRAIL $GRALTervis	0,19%			-
Beam Therapeutics $BEAMTervis	0,19%			-
Atai Beckley $ATAITervis	0,19%			-
Trevi Therapeutics $TRVITervis	0,18%			-
Kodiak Sciences $KODTervis	0,18%			-
Ultragenyx Pharmaceutical $RARETervis	0,18%			-
Nurix Therapeutics $NRIXTervis	0,18%			-
Tarsus Pharmaceuticals $TARSTervis	0,18%			-
BioCryst $BCRXTervis	0,17%			-
Vericel $VCELTervis	0,17%			-
Vera Therapeutics $VERATervis	0,17%			-
uniQure $QURETervis	0,16%			-
Pharvaris $PHVSTervis	0,16%			-
Mineralys Therapeutics, Inc. $MLYSTervis	0,16%			-
Amylyx Pharmaceuticals, Inc. $AMLXTervis	0,15%			-
Genmab $GMABTervis	0,15%			-
Agios $AGIOTervis	0,15%			-
	0,15%	N/A	N/A	N/A
Sionna Therapeutics, Inc. $SIONTervis	0,15%			-
Iovance Biotherapeutics $IOVATervis	0,15%			-
Harmony Biosciences $HRMYTervis	0,14%			-
Rapport Therapeutics, Inc. $RAPPTervis	0,14%			-
Zenas BioPharma, Inc. $ZBIOTervis	0,14%			-
ADMA Biologics $ADMATervis	0,14%			-
UroGen Pharma $URGNTervis	0,14%			-
Precigen $PGENTervis	0,14%			-
Fortrea Holdings $FTRETervis	0,14%			-
GH Research $GHRSTervis	0,14%			-
Aurinia Pharmaceuticals $AUPHTervis	0,13%			-
NovoCure $NVCRTervis	0,13%			-
Ocular Therapeutix $OCULTervis	0,13%			-
Monte Rosa Therapeutics $GLUETervis	0,13%			-
Stoke Therapeutics $STOKTervis	0,13%			-
ANI Pharmaceuticals $ANIPTervis	0,13%			-
Tyra Biosciences $TYRATervis	0,13%			-
Syndax Pharmaceuticals $SNDXTervis	0,12%			-
Bicara Therapeutics $BCAXTervis	0,12%			-
Sarepta Therapeutics $SRPTTervis	0,11%			-
Innoviva $INVATervis	0,11%			-
Zymeworks $ZYMETervis	0,11%			-
Recursion Pharmaceuticals $RXRXTervis	0,11%			-
Abcellera Biologics $ABCLTervis	0,11%			-
Taysha Gene Therapies $TSHATervis	0,11%			-
Legend Biotech $LEGNTervis	0,11%			-
Maze Therapeutics, Inc. $MAZETervis	0,11%			-
Xencor $XNCRTervis	0,11%			-
AnaptysBio $ANABTervis	0,11%			-
Intellia Therapeutics $NTLATervis	0,11%			-
Septerna Inc $SEPNTervis	0,1%			-
Immunocore $IMCRTervis	0,1%			-
Vir Biotechnology $VIRTervis	0,1%			-
Harrow Health $HROWTervis	0,1%			-
First Tracks Biotherapeutics $TRAXTervis	0,1%			-
Compass Pathways $CMPSTervis	0,1%			-
Xeris Biopharma Holdings, Inc. $XERSTervis	0,1%			-
ArriVent BioPharma $AVBPTervis	0,1%			-
Eton Pharmaceuticals $ETONTervis	0,09%			-
Ardelyx $ARDXTervis	0,09%			-
Personalis $PSNLTervis	0,09%			-
Novavax $NVAXTervis	0,09%			-
Oric Pharmaceuticals $ORICTervis	0,09%			-
MannKind $MNKDTervis	0,08%			-
Collegium Pharmaceutical $COLLTervis	0,08%			-
Inhibrx Biosciences $INBXTervis	0,08%			-
Absci $ABSITervis	0,08%			-
Wave Life Sciences $WVETervis	0,08%			-
Corvus Pharmaceuticals $CRVSTervis	0,08%			-
Savara $SVRATervis	0,08%			-
MeiraGTx $MGTXTervis	0,08%			-
Vor Biopharma $VORTervis	0,08%			-
Pacira BioSciences $PCRXTervis	0,07%			-
Cullinan Therapeutics $CGEMTervis	0,07%			-
Olema Pharmaceuticals $OLMATervis	0,07%			-
EyePoint Pharmaceuticals $EYPTTervis	0,07%			-
Bioage Labs Inc $BIOATervis	0,07%			-
Geron $GERNTervis	0,07%			-
Alvotech $ALVOTervis	0,07%			-
Maravai LifeSciences $MRVITervis	0,07%			-
	0,07%	N/A	N/A	N/A
Janux Therapeutics $JANXTervis	0,07%			-
Phathom Pharmaceuticals $PHATTervis	0,07%			-
Sana Biotechnology $SANATervis	0,06%			-
Arbutus Biopharma $ABUSTervis	0,06%			-
Theravance Biopharma $TBPHTervis	0,06%			-
Amphastar Pharmaceuticals $AMPHTervis	0,06%			-
Omeros $OMERTervis	0,06%			-
Annexon $ANNXTervis	0,06%			-
Kura Oncology $KURATervis	0,06%			-
Solid Biosciences Inc. $SLDBTervis	0,05%			-
Mesoblast $MESOTervis	0,05%			-
Design Therapeutics $DSGNTervis	0,05%			-
Phibro Animal Health $PAHCTervis	0,05%			-
Aclaris Therapeutics $ACRSTervis	0,05%			-
Castle Biosciences $CSTLTervis	0,05%			-
Rigel Pharmaceuticals, Inc. $RIGLTervis	0,05%			-
Aura Biosciences $AURATervis	0,05%			-
Candel Therapeutics $CADLTervis	0,05%			-
CytomX $CTMXTervis	0,05%			-
Ironwood Pharmaceuticals $IRWDTervis	0,05%			-
Zevra Therapeutics $ZVRATervis	0,04%			-
Zai Lab $ZLABTervis	0,04%			-
Prime Medicine, Inc. $PRMETervis	0,04%			-
Altimmune $ALTTervis	0,04%			-
Tectonic Therapeutic Inc $TECXTervis	0,04%			-
Allogene Therapeutics $ALLOTervis	0,04%			-
CorMedix $CRMDTervis	0,04%			-
ARS Pharmaceuticals $SPRYTervis	0,04%			-
4D Molecular Therapeutics $FDMTTervis	0,04%			-
Neurogene, Inc. $NGNETervis	0,04%			-
Arvinas $ARVNTervis	0,04%			-
Silence Therapeutics $SLNTervis	0,03%			-
REGENXBIO $RGNXTervis	0,03%			-
Aquestive Therapeutics $AQSTTervis	0,03%			-
Prothena $PRTATervis	0,03%			-
Pacific Biosciences $PACBTervis	0,03%			-
Cabaletta Bio $CABATervis	0,03%			-
Sagimet Biosciences Inc $SGMTTervis	0,03%			-

Fondide andmed (osalused, riigid ja sektorid) pärinevad BlackRock veebisaidilt. Viimati muudetud: 30. juuli 2026. See teave on üksnes informatiivne ja selle täpsus või täielikkus ei ole tagatud.

iShares Nasdaq US Biotechnology varade ülevaade

Lightyear

Õiguslik

Liitu meiega